Expression and function of bcl-2 proteins in melanoma

Jürgen Eberle1, Amir M Hossini

  • 1Charité - Universitätsmedizin Berlin, Department of Dermatology and Allergy, Skin Cancer Center Charité, Berlin, Germany.

Current Genomics
|June 10, 2009
PubMed

Insights

Bcl-2 proteins regulate cell death pathways. Targeting these proteins, particularly in melanoma, offers promising therapeutic strategies for overcoming apoptosis resistance.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Biology

Background:

  • Bcl-2 proteins are key regulators of mitochondrial membrane permeability and apoptosis.
  • The Bcl-2 family includes pro- and antiapoptotic proteins with conserved Bcl-2 homology (BH) domains.
  • Survival pathways like MAP kinases and Akt influence Bcl-2 protein expression and activity.

Purpose of the Study:

  • To review the role of Bcl-2 proteins in apoptosis resistance, especially in melanoma.
  • To discuss current and emerging therapeutic strategies targeting Bcl-2 proteins.

Main Methods:

  • Literature review of Bcl-2 protein function and regulation.
  • Analysis of Bcl-2 protein involvement in melanoma apoptosis resistance.
  • Overview of therapeutic approaches including antisense therapy and small molecule mimetics.

Main Results:

  • Bcl-2 proteins are crucial for maintaining mitochondrial integrity and controlling apoptosis.
  • Dysregulation of Bcl-2 proteins contributes significantly to apoptosis resistance in melanoma.
  • Clinical trials are investigating antisense-Bcl-2 strategies for melanoma treatment.

Conclusions:

  • Bcl-2 proteins are vital targets for cancer therapy, particularly in melanoma.
  • Strategies like antisense therapy and BH3 mimetics show promise in overcoming apoptosis resistance.
  • Further research into Bcl-2 family interactions may yield novel therapeutic interventions.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...